Jazz Pharmaceuticals plc buy Wells Fargo & Company
Start price
18.11.25
/
50%
€155.95
Target price
18.11.26
€202.73
Performance (%)
-6.93%
Price
16:00
€145.15
Summary
This prediction is currently active. With a performance of -6.93%, the BUY prediction by Wells_Fargo___Compan is trending in the wrong direction. This prediction currently runs until 18.11.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | 6.496% | 6.496% |
| iShares Core DAX® | 0.191% | 4.771% |
| iShares Nasdaq 100 | -0.614% | 3.137% |
| iShares Nikkei 225® | 0.599% | 8.016% |
| iShares S&P 500 | -0.036% | 3.593% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Wells Fargo & Company from $170.00 to $235.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€130.00
13.02.25
13.02.25
€163.54
13.02.26
13.02.26
11.65%
16:00
16:00
